scispace - formally typeset
R

Ramesh Natarajan

Researcher at Virginia Commonwealth University

Publications -  157
Citations -  12726

Ramesh Natarajan is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Ascorbic acid & Pulmonary hypertension. The author has an hindex of 42, co-authored 153 publications receiving 11365 citations. Previous affiliations of Ramesh Natarajan include VCU Medical Center & June.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial

Alpha A. Fowler, +35 more
- 01 Oct 2019 - 
TL;DR: In this preliminary study of patients with sepsis and ARDS, a 96-hour infusion of vitamin C compared with placebo did not significantly improve organ dysfunction scores or alter markers of inflammation and vascular injury.
Journal ArticleDOI

Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.

Puneet Puri, +6 more
- 01 Feb 2008 - 
TL;DR: Although both NAFL and NASH are associated with eIF-2alpha phosphorylation, there is a failure to activate downstream recovery pathways, ie, ATF4-CHOP-GADD34.
Journal ArticleDOI

Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure

Harm Jan Bogaard, +8 more
- 17 Nov 2009 - 
TL;DR: In this article, a mechanical animal model of chronic progressive pulmonary arterial pressure overload (pulmonary artery banding, not associated with structural alterations of the lung circulation) was compared with an established model of angioproliferative pulmonary hypertension associated with fatal RV failure.
Journal ArticleDOI

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Alpha A. Fowler, +12 more
- 31 Jan 2014 - 
TL;DR: Intravenous ascorbic acid infusion was safe and well tolerated in this study and may positively impact the extent of multiple organ failure and biomarkers of inflammation and endothelial injury.